John Burkhardt is a Pfizer senior vice president and the director of Pfizer’s Connecticut laboratories. In a recent op-ed he writes:
We’ve enjoyed a good partnership with our elected leaders in Connecticut, who continue to ensure … innovation is possible, which is why I was extremely disappointed to see the introduction of HB 6447, An Act Creating The Covered Connecticut Program To Expand Access To Affordable Health Care in the General Assembly. While we can all agree that the bill title is something to strive for, enacting the bill itself could have serious negative impacts on innovation, research and development investment here in Connecticut.